v3.26.1
Stockholders’ Equity (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 12 Months Ended
Feb. 23, 2026
Jan. 19, 2023
Dec. 31, 2023
Mar. 31, 2026
Mar. 31, 2025
Dec. 31, 2025
Dec. 31, 2024
Jul. 11, 2023
Jul. 10, 2023
EquityLineitems [Line Items]                  
Common stock, shares authorized       975,000,000   975,000,000      
Common stock par value       $ 0.001   $ 0.001      
Common stock, shares issued       49,775,371   46,852,737      
Common stock, shares outstanding       49,775,371   46,852,737      
Share repurchase program, remaining authorized, amount       $ 46,000,000          
Unvested equity awards outstanding       2,681,835        
Weighted-average grant date fair value of restricted stock       $ 2.63        
Sharebased compensation arrangement by sharebased payment award, options, grants in period, gross       690,300 1,427,068        
Accrued bonuses current and non current       $ 251,000   $ 1,609,000      
Share based payment issued, value       2,656,443 $ 3,860,367        
Stock based compensation expenses       $ 1,981,770          
Weighted average remaining period       5 years 8 months 12 days 4 years 1 month 6 days   1 year 8 months 12 days    
Each Independent Director [Member]                  
EquityLineitems [Line Items]                  
Stock option grant date fair value   $ 50,000              
Each Independent Director [Member] | Four Equal Installments [Member]                  
EquityLineitems [Line Items]                  
Stock option grant date fair value   $ 12,500              
Independent Directors [Member]                  
EquityLineitems [Line Items]                  
Share based payment issued, shares       26,979 25,002        
Share based payment issued, value       $ 37,500 $ 38,000        
Restricted Stock Units (RSUs) [Member]                  
EquityLineitems [Line Items]                  
Market cap vesting thresholds, value           $ 300,000,000      
Restricted Stock [Member]                  
EquityLineitems [Line Items]                  
Vesting of restricted stock unit 2,590,897                
Market Capitalization-Based Vesting Conditions [Member]                  
EquityLineitems [Line Items]                  
Weighted-average grant date fair value of restricted stock       $ 2.21          
Unrestricted Stock [Member]                  
EquityLineitems [Line Items]                  
Weighted average remaining period       6 months 14 days          
Unrecognized stock-based compensation cost       $ 11,793,973          
Weighted average remaining period       1 year 11 months 23 days          
2021 Equity Incentive Plan [Member]                  
EquityLineitems [Line Items]                  
Number of restricted stock units granted and vested, shares       2,712,108       12,000,000 7,000,000
Shares remaining available for future grants       205,647          
2026 Long Term Incentive [Member]                  
EquityLineitems [Line Items]                  
Number of restricted stock units granted and vested, shares       5,424,248          
2026 Long Term Incentive [Member] | Service-Based (Time) Vesting Conditions [Member]                  
EquityLineitems [Line Items]                  
Unvested equity awards outstanding       2,636,380          
2026 Long Term Incentive [Member] | Stock Price-Based Vesting Conditions [Member]                  
EquityLineitems [Line Items]                  
Unvested equity awards outstanding       1,318,210          
2026 Long Term Incentive [Member] | Market Capitalization-Based Vesting Conditions [Member]                  
EquityLineitems [Line Items]                  
Unvested equity awards outstanding       1,318,142          
Shareholders Approval [Member]                  
EquityLineitems [Line Items]                  
Number of restricted stock units granted and vested, shares       2,712,140          
Common Stock [Member]                  
EquityLineitems [Line Items]                  
Unvested equity awards outstanding       3,069,272   478,375      
Vesting of restricted stock unit       3,069,272 1,312,301        
Sharebased compensation arrangement by sharebased payment award, options, grants in period, gross       310,606 295,379        
Share based payment issued, shares       2,928,482 1,491,215        
Share based payment issued, value       $ 2,928 $ 1,491        
Common Stock [Member] | Officer [Member]                  
EquityLineitems [Line Items]                  
Fair value of shares issued       87,602 33,731        
Share based compensation       398,208 329,110        
Fair value of shares issued, value       $ 1,051,000 $ 813,000        
Series V Preferred Stock [Member]                  
EquityLineitems [Line Items]                  
Preferred stock, conversion basis description     the Company issued Series V Preferred Stock to shareholders on a one-for-one basis. The Series V is non-convertible, has a 20% liquidation preference over common stock, is non-voting, and includes certain rights to dividends and distributions at the discretion of the Board.            
Preferred stock, shares issued       15,671,405   15,671,405      
Preferred stock, shares outstanding       15,671,405   15,671,405      
Vesting of restricted stock unit       278,375 1,069,801        
Series V Preferred Stock [Member] | Preferred Stock [Member]                  
EquityLineitems [Line Items]                  
Fair value of shares issued       278,000          
Share based payment issued, shares         1,020,834        
Share based payment issued, value       $ 180,688        
Maximum [Member]                  
EquityLineitems [Line Items]                  
Share repurchase program authorized       50,000,000          
At-the-Market Offering Agreement [Member]                  
EquityLineitems [Line Items]                  
Sale of stock, number of shares issued in transaction       127,249          
Gross proceeds from issuance of common stock       $ 238,000          
Shares issued, price per share       $ 1.87          
Proceeds from issuance of stock net       $ 229,000          
At-the-Market Offering Agreement [Member] | H.C. Wainwright and Co., LLC [Member]                  
EquityLineitems [Line Items]                  
Securities issuance value       $ 2,000,000,000          
Percentage of sales commission       3.00%